Quantitative proteomics of Alzheimer's-like cerebral vasculature in TGF-ß1 overexpressing mice and its perturbation by pioglitazone

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.jalz.2012.05.1742
AuthorSearch for: ; Search for: 1 ; Search for: 1 ; Search for:
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleAlzheimer's and Dementia
ISSN1552-5260
Volume8
Issue4
Article numberSupplement
PagesP650–
SubjectTGF-ß1; Alzheimer's disease; cerebral vasculature; brain
Abstract
Elevation of transforming growth factor-beta 1 (TGFβ1), a key extracellular matrix regulator, has been documented in the brain and cerebral vasculature of Alzheimer's disease (AD) patients. Transgenic mice overexpressing TGFβ1 in the brain (TGF mice) develop AD-like vascular structural changes, impaired vasomotricity, and compromised neurovascular coupling. We have demonstrated that cerebrovascular dysfunction in both aged and young TGF mice is normalized by the peroxisome proliferator-activated receptor-γ agonist pioglitazone. Our aims are to (a) characterize the cerebrovascular proteome of TGF mice and its perturbation by pioglitazone using label-free mass spectrometry-based quantitative proteomics, and (b) identify proteins that orchestrate pioglitazone-mediated recovery of cerebrovascular function.
Publication date
Terms of use
LanguageEnglish
Peer reviewedYes
NPARC number21275161
Export citationExport as RIS
Report a correctionReport a correction
Record identifier10f22b61-ac4e-4b82-ae3c-ed55da39516c
Record created2015-05-21
Record modified2016-05-09
Date modified:
Report a problem on this page